Medical devices, healthcare technology and the business of care
510(k) clearance · K261266

MOWANA Auto Duo

PENTAMASTER MEDIQ SDN BHD · Decision date Sep 17, 2026

MEDTECHLEDGER EXPLANATIONK261266

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on September 17, 2026 for MOWANA™ Auto Duo, submitted by PENTAMASTER MEDIQ SDN BHD of Simpang Ampat, Malaysia, under 510(k) number K261266. The device falls under the classification name Needle, Hypodermic, Single Lumen, regulation number 880.5570, product code FMI, with a General Hospital medical specialty and review panel. The application was received April 16, 2026, and was reviewed by a third party; the record lists it as a traditional 510(k), not a combination product, with no authorized Predetermined Change Control Plan.

SESE means the submission was cleared as substantially equivalent; it is not a PMA approval. The record does not describe the specific components, design features, or any changed item, and no summary statement is present in the supplied data. The correspondence is addressed to Dave Yungvirt, CEO of Third Party Review Group, LLC, in Henderson, Nevada, while the applicant contact is listed as Thean Lye Ong. Details of the predicate comparison and the basis for the equivalence determination remain outside the provided material.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General Hospital
Decision date
Sep 17, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261266
Regulatory pathway
510(k) premarket notification
Product code
FMI
Decision code
SESE
Decision date
Sep 17, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Needle, Hypodermic, Single Lumen.

Product code
FMI
FDA device class
2

FDA decision timeline

  1. K261266 received

    Application receipt date recorded by FDA.

  2. K261266 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

PENTAMASTER MEDIQ SDN BHD

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Simpang Ampat

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records